Carl Zeiss Meditec AG

AFXA

Company Profile

  • Business description

    Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.

  • Contact

    Goschwitzer Strasse 51-52
    JenaTH07745
    DEU

    T: +49 3641220115

    https://www.zeiss.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    30 September 2026

    Employees

    5,798

Stocks News & Analysis

stocks

Global tensions drive profitability for ASX energy provider

Supply disruptions turbocharge refining profits and lift earnings forecasts for ASX energy share.
stocks

ASX energy share undervalued ahead of earnings

Pricing strength outweighs temporary production headwinds.
stocks

Tesla: Reported China divestiture plan could clear path for SpaceX merger

Media report says Tesla is exploring divestiture plans to ease regulatory approval of a Tesla-SpaceX merger.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,311.90125.801.37%
CAC 408,613.490.33-0.00%
DAX 4026,161.13159.820.61%
Dow JONES (US)53,178.41693.381.32%
FTSE 10010,891.8934.190.31%
HKSE25,852.92156.48-0.60%
NASDAQ25,913.90540.042.13%
Nikkei 22563,957.53202.630.32%
NZX 50 Index13,903.46128.530.93%
S&P 5007,600.50110.781.48%
S&P/ASX 2009,145.80122.801.36%
SSE Composite Index3,822.2812.620.33%

Market Movers